Frank Lamberti - Nov 1, 2025 Form 3 Insider Report for HERBALIFE LTD. (HLF)

Role
Chief Commercial Officer
Signature
Alaaeddine Sahibi, as Attorney-In-Fact for Frank Lamberti
Stock symbol
HLF
Transactions as of
Nov 1, 2025
Transactions value $
$0
Form type
3
Date filed
11/12/2025, 06:28 PM
Previous filing
May 7, 2024
Next filing
Nov 18, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lamberti Frank Chief Commercial Officer 800 W. OLYMPIC BLVD., SUITE 406, LOS ANGELES Alaaeddine Sahibi, as Attorney-In-Fact for Frank Lamberti 2025-11-12 0001661501

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HLF Common Stock 188K Nov 1, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HLF Stock Appreciation Rights Nov 1, 2025 Common Stock 12.5K $27.38 Direct F2
holding HLF Stock Appreciation Rights Nov 1, 2025 Common Stock 30.2K $31.26 Direct F3
holding HLF Stock Appreciation Rights Nov 1, 2025 Common Stock 31.8K $28.60 Direct F4
holding HLF Stock Appreciation Rights Nov 1, 2025 Common Stock 80K $13.60 Direct F5
holding HLF Stock Appreciation Rights Nov 1, 2025 Common Stock 64.4K $18.61 Direct F6
holding HLF Stock Appreciation Rights Nov 1, 2025 Common Stock 213K $9.58 Direct F7
holding HLF Stock Appreciation Rights Nov 1, 2025 Common Stock 77.4K $8.31 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance includes 134,982 shares of the Issuer's common stock and 31,699 unvested restricted stock units ("RSUs") previously granted to the Reporting Person, of which: 3,983 RSUs will vest on May 4, 2026; 3,359 RSUs will vest on August 4, 2026; 12,178 RSUs will vest on May 3, 2026; and 12,179 RSUs will vest on May 3, 2027. Each of the aforementioned grants is subject to the following vesting schedule: one-third of the award on each of the first, second, and third anniversaries of the grant date, subject to continued service through each applicable vesting date. Balance also includes 21,086 shares of the Issuer's common stock to which the Reporting Person became entitled upon vesting of RSUs, receipt of which the Reporting Person has elected to defer.
F2 These stock appreciation rights were fully vested as of February 29, 2019.
F3 These stock appreciation rights were fully vested as of May 9, 2019.
F4 These stock appreciation rights were fully vested as of February 27, 2020.
F5 On May 4, 2023, the reporting person was granted 80,049 stock appreciation rights, of which 2/3 have vested, and 1/3 will vest on May 4, 2026, subject to continued service through such date.
F6 On August 4, 2023, the reporting person was granted 64,432 stock appreciation rights, of which 2/3 have vested, and 1/3 will vest on August 4, 2026, subject to continued service through such date.
F7 On May 3, 2024, the reporting person was granted 212,550 stock appreciation rights, of which 1/3 has vested, 1/3 will vest on May 3, 2026, and 1/3 will vest on May 3, 2027, subject to continued service through each applicable vesting date.
F8 On February 21, 2025, the reporting person was granted 77,433 stock appreciation rights, of which 1/3 will vest on February 21, 2026, 1/3 will vest on February 21, 2027, and 1/3 will vest on February 21, 2028, subject to continued service through each applicable vesting date.